IDEAYA Biosciences, Inc.
IDYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,859,681 | $1,447,271 | $2,244,664 |
| - Cash | $298,927 | $114,645 | $129,996 | $84,378 |
| + Debt | $26,917 | $26,597 | $25,968 | $19,171 |
| Enterprise Value | – | $1,771,633 | $1,343,243 | $2,179,457 |
| Revenue | $207,834 | $0 | $0 | $7,000 |
| % Growth | – | – | -100% | – |
| Gross Profit | $206,804 | -$1,233 | -$1,133 | $6,357 |
| % Margin | 99.5% | – | – | 90.8% |
| EBITDA | $120,274 | -$76,258 | -$71,045 | -$129,669 |
| % Margin | 57.9% | – | – | -1,852.4% |
| Net Income | $119,244 | -$77,491 | -$72,178 | -$130,312 |
| % Margin | 57.4% | – | – | -1,861.6% |
| EPS Diluted | 1.33 | -0.88 | -0.82 | -1.49 |
| % Growth | 251.1% | -7.3% | 45% | – |
| Operating Cash Flow | $142,214 | -$62,474 | -$60,342 | -$121,655 |
| Capital Expenditures | -$42 | -$663 | -$1,330 | -$1,102 |
| Free Cash Flow | $142,172 | -$63,137 | -$61,672 | -$122,757 |